In silico approach on drug repurposing - Antimalarial drugs against HIV-1 protease
Arulanandam, C. D.
Show abstract
Acquired Immunodeficiency Syndrome (AIDS), belonging to the retrovirus family is one of the most devastating contagious diseases of this century. Most of the available approved drugs are small molecules which are used in antiretroviral therapy (ART) that trigger the therapeutic response through binding to a targeted protein, HIV-1 protease (PR). This protein represents the most important antiretroviral drug target due to its key role in viral development inhibition. Computational tools using computer-aided technologies have proven useful in accelerating the drug discovery. In this study we evaluated selected FDA (USA) approved antimalarial drugs against HIV-1 protease to find a potential inhibitor candidate for HIV-1 PR (PDB 6DJ1). Binding affinities and Ki inhibition constant of an AutoDock 4.2 study suggest that of all assessed antimalarial agents, Lumefantrine (LUM) would be a most promising HIV-1 PR inhibitor.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 97%
- Molecular Basis for Reduced Cleavage Activity and Drug Resistance in D30N HIV-1 protease 95%
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 95%
Similar papers in this journal
- Computationally Grafting an IgE Epitope onto a Scaffold: Implications for a Pan Anti-Allergy Vaccine Design 92%
- DenovoProfiling: a webserver for de novo generated molecule library profiling 92%
- Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model 92%
Similar papers in this journal
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 95%
- Treatment Profiles And Clinical Outcomes Of COVID-19 Patients At Private Hospital In Jakarta 94%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 94%
Similar papers in this journal
- Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India 92%
- Glibenclamide, ATP and Metformin Increases the Expression of Human Bile Salt Export Pump ABCB11 91%
- SNPector: SNP inspection tool for diagnosing gene pathogenicity and drug response in a naked sequence 90%
Similar papers in this journal
- Deciphering inhibitory mechanism of coronavirus replication through host miRNAs-RNA-dependent RNA polymerase (RdRp) interactome 91%
- Genomic variations in SARS-CoV-2 genomes from Gujarat: Underlying role of variants in disease epidemiology 91%
- Universal nature of drug treatment responses in drug-tissue-wide model-animal experiments using tensordecomposition-based unsupervised featureextraction 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.